keyword
https://read.qxmd.com/read/38529334/stress-hyperglycemia-and-poor-outcomes-in-patients-with-st-elevation-myocardial-infarction-a-systematic-review-and-meta-analysis
#1
Abdul Hakim Alkatiri, Nurul Qalby, Idar Mappangara, Ahmad Taufik F Zainal, Maarten J Cramer, Pieter A Doevendans, Andriany Qanitha
BACKGROUND: Hyperglycemia, characterized by elevated blood glucose levels, is frequently observed in patients with acute coronary syndrome, including ST-elevation myocardial infarction (STEMI). There are conflicting sources regarding the relationship between hyperglycemia and outcomes in STEMI patients. We aimed to compile evidence to assess the association between hyperglycemia and adverse outcomes. METHODS: We conducted a comprehensive search for articles on PubMed and Embase using search strategies which yielded 4,061 articles...
2024: Frontiers in Cardiovascular Medicine
https://read.qxmd.com/read/38510102/syphilitic-ostial-coronary-artery-occlusion-treated-with-percutaneous-coronary-intervention-case-series-and-literature-review
#2
JOURNAL ARTICLE
Yasmine Baydoun, Yuriy Stukov, Matthew S Purlee, Bailey Chagnon, Sergiy V Salo, Andrii Y Gavrylyshin, Vasyl Lazoryshynets, Olena Levchyshyna, Omar M Sharaf, Giles J Peek, Mark S Bleiweis, Jeffrey P Jacobs
INTRODUCTION: Non-atherosclerotic causes of acute coronary syndrome (ACS) are important contributors to a substantial number of acute ischemic coronary events. Syphilitic aortitis is a rare complication of tertiary cardiovascular syphilis that may result in ostial coronary artery stenosis, aortic insufficiency, and ascending aortic aneurysm. METHODS: In this manuscript, we present two Case Reports of patients with bilateral syphilitic coronary artery ostial occlusion, and we review the associated literature...
December 2023: American heart journal plus: cardiology research and practice
https://read.qxmd.com/read/38506475/preinterventional-pan-immune-inflammation-value-as-a-tool-to-predict-postcontrast-acute-kidney-injury-among-acute-coronary-syndrome-patients-implanted-drug-eluting-stents-a-retrospective-observational-study
#3
JOURNAL ARTICLE
Alparslan Kurtul, Murat Gok
We evaluated the value of pan-immune-inflammation value (PIV) in predicting the risk for postcontrast acute kidney injury (PCAKI), an important complication following percutaneous coronary intervention (PCI) in acute coronary syndrome (ACS) patients. Medical records of 839 ACS patients underwent PCI between June 2019 and December 2022 were retrospectively analyzed. Patients were divided into two groups: PCAKI (-) and PCAKI (+). PCAKI was defined as a  ≥ 0.5 mg/dL and/or a  ≥ 25% increase in serum creatinine within 72 h after PCI...
March 20, 2024: Scandinavian Journal of Clinical and Laboratory Investigation
https://read.qxmd.com/read/38503613/efficacy-and-safety-of-tongxin-formula-after-stent-implantation-for-acute-coronary-syndrome-a-multicenter-double-blind-placebo-controlled-randomized-trial
#4
JOURNAL ARTICLE
Wen Zhu, Su Wang, Lei Zhang, Feng-Qun Xie, Jie Cheng, Xian-Kai Li, Wei Chen, Shi-Yun Yan, Qi-Mao Feng
OBJECTIVE: The aim of this study is to comprehensively evaluate both the efficacy and safety profile of integrating the Tongxin formula with optimal medical therapy (OMT) for patients experiencing acute coronary syndromes subsequent to coronary stenting, over the course of one year. METHODS: We enrolled 150 patients diagnosed with acute coronary syndromes who had received stent placement within one month and exhibited a TCM syndrome characterized by Qi deficiency and blood stasis...
March 1, 2024: Explore: the Journal of Science and Healing
https://read.qxmd.com/read/38493327/prognosis-of-patients-with-crohn-s-disease-and-ulcerative-colitis-following-percutaneous-coronary-intervention-procedures
#5
JOURNAL ARTICLE
Jill Savren Lotker, Ariel Roguin, Arthur Kerner, Erez Marcusohn, Ofer Kobo
BACKGROUND: Patients with inflammatory bowel disease (IBD) are at increased risk after percutaneous coronary intervention (PCI). OBJECTIVES: To compare the clinical outcomes within 30 days, one year, and five years of undergoing PCI. METHODS: We conducted a retrospective cohort study of adult patients with IBD who underwent PCI in a tertiary care center from January 2009 to December 2019. RESULTS: We included 44 patients, 26 with Crohn's disease (CD) and 18 with ulcerative colitis (UC), who underwent PCI...
March 2024: Israel Medical Association Journal: IMAJ
https://read.qxmd.com/read/38487882/no-reflow-prediction-in-acute-coronary-syndrome-during-percutaneous-coronary-intervention-the-norpacs-risk-score
#6
JOURNAL ARTICLE
Luke P Dawson, Muhammad Rashid, Diem T Dinh, Angela Brennan, Jason E Bloom, Sinjini Biswas, Jeffrey Lefkovits, James A Shaw, William Chan, David J Clark, Ernesto Oqueli, Chin Hiew, Melanie Freeman, Andrew J Taylor, Christopher M Reid, Andrew E Ajani, David M Kaye, Mamas A Mamas, Dion Stub
BACKGROUND: Suboptimal coronary reperfusion (no reflow) is common in acute coronary syndrome percutaneous coronary intervention (PCI) and is associated with poor outcomes. We aimed to develop and externally validate a clinical risk score for angiographic no reflow for use following angiography and before PCI. METHODS: We developed and externally validated a logistic regression model for prediction of no reflow among adult patients undergoing PCI for acute coronary syndrome using data from the Melbourne Interventional Group PCI registry (2005-2020; development cohort) and the British Cardiovascular Interventional Society PCI registry (2006-2020; external validation cohort)...
March 15, 2024: Circulation. Cardiovascular Interventions
https://read.qxmd.com/read/38482634/benefits-of-immediate-complete-revascularization-in-patients-with-acute-coronary-syndromes
#7
JOURNAL ARTICLE
Jacob J Elscot, Hala Kakar, Anniek C Ziedses DES Plantes, Roberto Diletti, Nicolas M VAN Mieghem
Acute coronary syndrome is one of the leading causes of death worldwide. Up to 60% of patients present with additional significant non-culprit lesions. Complete revascularization (CR) of all (culprit and non-culprit) lesions is recommended and recent randomized trials showed the benefit of performing complete multivessel percutaneous coronary intervention in a single setting. Immediate CR is associated with a reduced risk of repeat myocardial infarction and unplanned ischemia driven revascularization. Furthermore, immediate CR resulted in less implanted stents, total contrast use and a shorter duration of hospitalization while maintaining a similar success rate of complete revascularization...
March 14, 2024: Minerva cardiology and angiology
https://read.qxmd.com/read/38477913/quantitative-coronary-angiography-vs-intravascular-ultrasonography-to-guide-drug-eluting-stent-implantation-a-randomized-clinical-trial
#8
JOURNAL ARTICLE
Pil Hyung Lee, Soon Jun Hong, Hyun-Sook Kim, Young Won Yoon, Jong-Young Lee, Seung-Jin Oh, Ji Sung Lee, Soo-Jin Kang, Young-Hak Kim, Seong-Wook Park, Seung-Whan Lee, Cheol Whan Lee
IMPORTANCE: Although intravascular ultrasonography (IVUS) guidance promotes favorable outcomes after percutaneous coronary intervention (PCI), many catheterization laboratories worldwide lack access. OBJECTIVE: To investigate whether systematic implementation of quantitative coronary angiography (QCA) to assist angiography-guided PCI could be an alternative strategy to IVUS guidance during stent implantation. DESIGN, SETTING, AND PARTICIPANTS: This randomized, open-label, noninferiority clinical trial enrolled adults (aged ≥18 years) with chronic or acute coronary syndrome and angiographically confirmed native coronary artery stenosis requiring PCI...
March 13, 2024: JAMA Cardiology
https://read.qxmd.com/read/38425817/a-2024-scientific-update-on-the-clinical-performance-of-drug-coated-balloons
#9
REVIEW
Florin-Leontin Lazar, Horea-Laurentiu Onea, Dan-Mircea Olinic, Bernardo Cortese
Continuous advances in the field of interventional cardiology have led to the development of drug-coated balloons (DCB). These represent a promising device for overcoming the well-known limitations of traditional metallic stents, which are associated with a persistent yearly increased risk of adverse events. This technology has the ability to homogeneously transfer the drug into the vessel wall in the absence of a permanent prosthesis implanted in the coronary vessel. Robust data support the use of DCB for the treatment of in-stent restenosis, but there is also currently growing evidence from long-term follow-up of large randomised clinical trials regarding the use of these devices in other scenarios, such as de novo small and large vessel disease, complex bifurcations, and diffuse coronary disease...
February 2024: AsiaIntervention
https://read.qxmd.com/read/38414923/treatment-of-coronary-lesions-with-a-novel-crystalline-sirolimus-coated-balloon
#10
JOURNAL ARTICLE
Mehdi Madanchi, Adrian Attinger-Toller, Varis Gjergjizi, Irena Majcen, Giacomo M Cioffi, Angelika Epper, Eleonora Gnan, Tanja Koch, Yuan Zhi, Florim Cuculi, Matthias Bossard
BACKGROUND: There is mounting data supporting the use of drug-coated balloons (DCB) not only for treatment of in-stent restenosis (ISR), but also in native coronary artery disease. So far, paclitaxel-coated balloons represented the mainstay DCBs. The SeQuent® crystalline sirolimus-coated balloon (SCB) (B.Braun Medical Inc, Germany) represents a novel DCB, which allows a sustained release of the limus-drug. We evaluated its performance in an all-comer cohort, including complex coronary lesions...
2024: Frontiers in Cardiovascular Medicine
https://read.qxmd.com/read/38409069/systemic-immune-inflammation-index-and-in-stent-restenosis-in%C3%A2-patients-with%C3%A2-acute-coronary-syndrome-a-single-center-retrospective-study
#11
JOURNAL ARTICLE
Feng Xie, Zuozhong Yu, Yurong Xiong, Zhijian Wu, Yanqing Wu
BACKGROUND: In-stent restenosis (ISR) has been shown to be correlated with inflammation. This study aimed to examine the relationship between systemic immune-inflammation index (SII, an innovative inflammatory biomarker) and ISR in acute coronary syndrome (ACS) patients after drug-eluting stent (DES) implantation. METHODS: Subjects who were diagnosed with ACS and underwent DES implantation were enrolled retrospectively. All individuals underwent follow-up coronary angiography at six to forty-eight months after percutaneous coronary intervention (PCI)...
February 26, 2024: European Journal of Medical Research
https://read.qxmd.com/read/38384448/the-impact-of-patient-adherence-to-dual-antiplatelet-medication-following-percutaneous-coronary-intervention-on-the-occurrence-of-adverse-cardiovascular-events
#12
JOURNAL ARTICLE
J A Mansurova, Andrey Orekhov, A S Zhunuspekova, A A Kassymova, L K Karazhanova
BACKGROUND: The objective of this study is to examine the impact of medication adherence on the timing of non-cardiovascular serious events (NCDS) onset in patients with acute coronary syndrome (ACS) after percutaneous coronary intervention (PCI). METHODS: This prospective study was conducted at a single center and involved 220 ACS patients who underwent sequential PCI with stenting. The Morisky Green Levine Medication Adherence Scale was employed to assess adherence to dual antiplatelet therapy (DAPT) and its impact on NCDS occurrence...
2024: Patient Preference and Adherence
https://read.qxmd.com/read/38371282/cardiac-optical-coherence-tomography-history-current-status-and-perspective
#13
REVIEW
Taishi Yonetsu, Ik-Kyung Jang
For more than 2 decades since the first imaging procedure was performed in a living patient, intravascular optical coherence tomography (OCT), with its unprecedented image resolution, has made significant contributions to cardiovascular medicine in the realms of vascular biology research and percutaneous coronary intervention. OCT has contributed to a better understanding of vascular biology by providing insights into the pathobiology of atherosclerosis, including plaque phenotypes and the underlying mechanisms of acute coronary syndromes such as plaque erosion, neoatherosclerosis, stent thrombosis, and myocardial infarction with nonobstructive coronary arteries...
February 2024: JACC Asia
https://read.qxmd.com/read/38350507/long-term-pci-outcomes-in-chronic-versus-acute-coronary-syndromes-target-all-comers-trial
#14
JOURNAL ARTICLE
Kush P Patel, Alexandra J Lansky, Henning Kelbæk, Bo Xu, Niels van Royen, Thomas W Johnson, Richard Anderson, William Wijns, Andreas Baumbach
In the TARGET All Comers trial, the biodegradable-polymer sirolimus-eluting FIREHAWK stent (BP SES) was non-inferior to the durable-polymer everolimus-eluting XIENCE stent (DP EES) with respect to target lesion failure (TLF) at 1 and 5 years; however, long-term safety and efficacy in the setting of acute coronary syndromes (ACS) are not known. We sought to assess the long-term outcomes in ACS vs chronic coronary syndromes (CCS) with BP SES vs DP EES. The TARGET AC study was a multicenter, open-label, noninferiority trial of all comer patients randomized 1:1 to BP SES or DP EES (stratified by ST-elevation myocardial infarction and study site)...
February 11, 2024: American Journal of Cardiology
https://read.qxmd.com/read/38349586/changes-in-cardiac-electrical-biomarker-in-response-to-coronary-arterial-occlusion-an-experimental-observation
#15
JOURNAL ARTICLE
Sudipta Chattopadhyay, Felicia Adjei, Attila Kardos
Cardiac electrical biomarker (CEB), an indicator of ischaemia-induced change in myocyte polarity, has been proposed for diagnosis of acute coronary syndrome. However, effect of coronary occlusion on CEB has not been demonstrated. CEB was acquired before (CEB0), during maximal adenosine hyperaemia (CEBhyp), balloon inflations (CEBmax) and 1 (CEB1h), 2 (CEB2h) and 3 (CEB3h) h after percutaneous coronary intervention along with pre- and post-procedural troponin-I. CEB of subjects with non-cardiac chest pain without risk factors was used as controls (CEBc)...
February 13, 2024: Journal of Cardiovascular Translational Research
https://read.qxmd.com/read/38343186/design-and-fabrication-of-environmentally-responsive-nanoparticles-for-the-diagnosis-and-treatment-of-atherosclerosis
#16
REVIEW
Jingyue Wang, Bingyang Lu, Ge Yin, Li Liu, Ping Yang, Nan Huang, Ansha Zhao
Cardiovascular disease poses a significant threat to human health in today's society. A major contributor to cardiovascular disease is atherosclerosis (AS). The development of plaque in the affected areas involves a complex pathological environment, and the disease progresses rapidly. Nanotechnology, combined with emerging diagnostic and treatment methods, offers the potential for the management of this condition. This paper presents the latest advancements in environment-intelligent responsive controlled-release nanoparticles designed specifically for the pathological environment of AS, which includes characteristics such as low pH, high reactive oxygen species levels, high shear stress, and multienzymes...
February 11, 2024: ACS Biomaterials Science & Engineering
https://read.qxmd.com/read/38326065/-comparison-among-different-flushing-media-for-intracoronary-imaging-with-optical-coherence-tomography
#17
JOURNAL ARTICLE
B Li, Z B Li, J P Wang, L Zhao, Z H Wang, J D Wu, B Liu
Objective: To explore the effects and safety of saline mixed 1∶1 with contrast medium (mixed medium) and pure heparinized saline as alternative media for optimal Optical Coherence Tomography (OCT) guided percutaneous coronary intervention (PCI). Methods: This single-center, prospective cohort study enrolled patients who underwent PCI with OCT guidance for chronic stable angina or acute coronary syndrome at the Department of Cardiology, the Second Hospital of Jilin University from October 2021 to August 2022...
February 24, 2024: Zhonghua Xin Xue Guan Bing za Zhi
https://read.qxmd.com/read/38304580/percutaneous-coronary-intervention-with-a-drug-eluting-stent-versus-coronary-artery-bypass-grafting-in-patients-receiving-dialysis-a-national-study-from-taiwan
#18
JOURNAL ARTICLE
Szu-Yu Pan, Ju-Yeh Yang, Nai-Chi Teng, Yun-Yi Chen, Shi-Heng Wang, Chien-Lin Lee, Kang-Lung Chen, Yen-Ling Chiu, Shih-Ping Hsu, Yu-Sen Peng, Yung-Ming Chen, Shuei-Liong Lin, Likwang Chen
RATIONALE & OBJECTIVE: We aimed to study the comparative effectiveness of percutaneous coronary intervention with drug-eluting stent and coronary artery bypass grafting in patients receiving dialysis. STUDY DESIGN: This was a retrospective observational cohort study. SETTING & PARTICIPANTS: This population-based study identified patients receiving dialysis hospitalized for coronary revascularization between January 1, 2009 and December 31, 2015, in the Taiwan National Health Insurance Research Database...
February 2024: Kidney medicine
https://read.qxmd.com/read/38299468/safety-and-efficacy-results-of-percutaneous-renal-stent-implantation-in-patients-with-acute-coronary-syndrome-with-ectatic-and-aneurysmatic-coronary-arteries
#19
JOURNAL ARTICLE
Sencer Çamci, Hasan Ari, Ayşe Sünbül, Selma Ari, Mehmet Melek, Tahsin Bozat
BACKGROUND: For the treatment of stenotic lesions developing in dilated coronary arteries, it is difficult to find an appropriately sized coronary stent given that the vessel diameter is too large. This poses a greater problem, especially in patients who require urgent intervention, such as acute coronary syndrome. OBJECTIVE: We aimed to evaluate the efficacy and safety of renal stents implanted in ectatic/aneurysmatic coronary arteries in such patients. METHODS: In total, 18 patients (renal stent group) who underwent renal stent implantation in ectatic/aneurysmatic coronary arteries requiring percutaneous coronary intervention (PCI) and 45 patients who underwent large-sized bare-metal coronary stent (BMCS) implantation (BMCS group) at our center were included in the study...
February 1, 2024: Postgraduate Medicine
https://read.qxmd.com/read/38298759/management-and-outcomes-of-spontaneous-coronary-artery-dissection-a-systematic-review-of-the-literature
#20
REVIEW
Milovan Petrović, Tatjana Miljković, Aleksandra Ilić, Mila Kovačević, Milenko Čanković, Dragana Dabović, Anastazija Stojšić Milosavljević, Snežana Čemerlić Maksimović, Milana Jaraković, Dragica Andrić, Miodrag Golubović, Marija Bjelobrk, Snežana Bjelić, Snežana Tadić, Jelena Slankamenac, Svetlana Apostolović, Vladimir Djurović, Aleksandra Milovančev
BACKGROUND: Contemporary management of spontaneous coronary artery dissection (SCAD) is still controversial. This systematic review of the literature aims to explore outcomes in the patients treated with conservative management vs. invasive strategy. METHODS: The PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines were followed when we extensively searched three electronic databases: PubMed, ScienceDirect, and Web of Science, for studies that compared conservative vs...
2024: Frontiers in Cardiovascular Medicine
keyword
keyword
23467
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.